Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells Article

Simpkins, Fiona, Jang, Kibeom, Yoon, Hyunho et al. (2018). Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells . CLINICAL CANCER RESEARCH, 24(19), 4874-4886. 10.1158/1078-0432.CCR-17-3697

Open Access

cited authors

  • Simpkins, Fiona; Jang, Kibeom; Yoon, Hyunho; Hew, Karina E; Kim, Minsoon; Azzam, Diana J; Sun, Jun; Zhao, Dekuang; Ince, Tan A; Liu, Wenbin; Guo, Wei; Wei, Zhi; Zhang, Gao; Mills, Gordon B; Slingerland, Joyce M

sustainable development goals

authors

publication date

  • October 1, 2018

webpage

published in

keywords

  • ALDEHYDE DEHYDROGENASE
  • CARCINOMA
  • COMBINATION
  • DRUG
  • EPITHELIAL OVARIAN
  • IN-VIVO
  • Life Sciences & Biomedicine
  • Oncology
  • PATHWAY ACTIVATION
  • RESISTANCE
  • SELUMETINIB
  • Science & Technology
  • THERAPY

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 4874

end page

  • 4886

volume

  • 24

issue

  • 19